Additions to the Xantis executive team

In the recent months Xantis Pharma has made several significant additions to its executive team working in the Prague office. 


Mikulas “Miki” Lehocky, Director of Business Development, CE region. With two decades of experience in the Pharmaceutical sector, Miki joined Xantis Pharma from Saneca, where he established and built the Portfolio and Generic Business Division.


Arni Hrannar Haraldsson, SVP of Business Development & Supply Chain Management.  Arni has held different leadership roles within Actavis/Allergan for the last 16 years. At Actavis/Allergan he held various managerial roles within Operations, Out licensing, Business Development and Commercial. His role before joining Xantis Pharma was to lead the Strategic Launch Management & Generic Price & Reimbursement.


Jana Banhidaiova, General Manager - CZ and SK. Jana has held managerial roles in the pharmaceutical industry for over two decades. Before joining Xantis Pharma she was the General Manager for Actavis/Allergan in the Czech Republic. Previously she managed Ratiopharm in the Czech Republic. 

Tatiana Mahrlova, Country Lead. Tatiana has held various managerial marketing roles in the pharmaceutical sector of Slovakia for 15 years. She's worked at companies including Pliva and Zentiva. Tatiana joined Xantis Pharma from the Actavis/Allergan Slovak management team.


Natalia Kocankova, Director of Pharmacovigilance and EU QPPV. Natalia has been in pharmacovigilance leadership roles for more than 12 years. She has been responsible for harmonization as well as setting up of new PV systems across different regions - EU, non EU, USA and Japan. Previously she was responsible for pharmacovigilance in Glenmark, Boehringer Ingelheim, Sucampo, Pharmaswiss and Sanofi.